ArticleAntimicrobial agents and chemotherapy2014

The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance.

Udayan Chatterji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.